CLYM
Climb Bio
CLYM
CLYM
22 hedge funds and large institutions have $46.8M invested in Climb Bio in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $48.4M → $46.8M (-$1.59M)
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$383K | |
| 2 | +$40K | |
| 3 | +$23.3K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$22.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.18K |
Top Sellers
| 1 | -$210K | |
| 2 | -$170K | |
| 3 | -$7.53K | |
| 4 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$5.38K |
| 5 |
BlackRock
New York
|
-$2.27K |